Choice of estimand and analysis methods in diabetes trials with rescue medication

Author:

Holzhauer Björn1,Akacha Mouna2,Bermann Georgina1

Affiliation:

1. Novartis Pharma AG; Biostatistical Sciences and Pharmacometrics; Basel Switzerland

2. Novartis Pharma AG; Statistical Methodology and Consulting; Basel Switzerland

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Reference64 articles.

1. Assessing methods for dealing with treatment switching in randomised controlled trials: a simulation study;Morden;BMC Medical Research Methodology,2011

2. Estimating treatment effects with treatment switching via semicompeting risks models: an application to a colorectal cancer study;Zeng;Biometrika,2012

3. Adjusting treatment comparisons to account for nonrandomized interventions: an example from an angina trial;White;Statistics in Medicine,2003

4. Randomized clinical trials with added rescue medication: some approaches to their analysis and interpretation;White;Statistics in Medicine,2001

5. U.S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research Guidance for Industry - Diabetes Mellitus: Developing Drugs and Therapeutic Biologics for Treatment and Prevention (Draft Guidance).73 Federal Register 11420.2008

Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3